Literature DB >> 16900497

Overexpression of PRDM16 in the presence and absence of the RUNX1/PRDM16 fusion gene in myeloid leukemias.

Sawcène Hazourli, Pierre Chagnon, Martin Sauvageau, Raouf Fetni, Lambert Busque, Josée Hébert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16900497      PMCID： PMC5770209          DOI： 10.1002/gcc.20370

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


× No keyword cloud information.
  13 in total

1.  Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.

Authors:  M-J P L Stevens-Kroef; E F P M Schoenmakers; M van Kraaij; E Huys; S Vermeulen; B van der Reijden; A Geurts van Kessel
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

2.  Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).

Authors:  Ikuya Sakai; Tatsushiro Tamura; Hirosi Narumi; Naoyuki Uchida; Yoshihiro Yakushijin; Takaaki Hato; Shigeru Fujita; Masaki Yasukawa
Journal:  Genes Chromosomes Cancer       Date:  2005-11       Impact factor: 5.006

3.  The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.

Authors:  Vitalyi Senyuk; Donglan Li; Alexander Zakharov; Fady M Mikhail; Giuseppina Nucifora
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

4.  A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.

Authors:  N Mochizuki; S Shimizu; T Nagasawa; H Tanaka; M Taniwaki; J Yokota; K Morishita
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

Review 5.  The yin-yang of PR-domain family genes in tumorigenesis.

Authors:  G L Jiang; S Huang
Journal:  Histol Histopathol       Date:  2000-01       Impact factor: 2.303

6.  Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.

Authors:  Yang Du; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

7.  Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system.

Authors:  Nadine Mayotte; Denis-Claude Roy; Jing Yao; Evert Kroon; Guy Sauvageau
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

8.  Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.

Authors:  Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Claudia Erpelinck; Bob Löwenberg; Ruud Delwel
Journal:  Exp Hematol       Date:  2003-11       Impact factor: 3.084

9.  Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representation.

Authors:  Susan M Gribble; Alistair G Reid; Ian Roberts; Colin Grace; Anthony R Green; Elizabeth P Nacheva
Journal:  Genes Chromosomes Cancer       Date:  2003-08       Impact factor: 5.006

10.  Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.

Authors:  Idoya Lahortiga; Xabier Agirre; Elena Belloni; Iria Vázquez; María J Larrayoz; Patrizia Gasparini; Francesco Lo Coco; Pier Giuseppe Pelicci; María J Calasanz; María D Odero
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867
View more
  6 in total

1.  Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

Authors:  Norio Shiba; Kenichi Yoshida; Yusuke Hara; Genki Yamato; Yuichi Shiraishi; Hidemasa Matsuo; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Taeko Kaburagi; Masanobu Takeuchi; Kentaro Ohki; Masashi Sanada; Jun Okubo; Daisuke Tomizawa; Tomohiko Taki; Akira Shimada; Manabu Sotomatsu; Keizo Horibe; Takashi Taga; Souichi Adachi; Akio Tawa; Satoru Miyano; Seishi Ogawa; Yasuhide Hayashi
Journal:  Blood Adv       Date:  2019-10-22

2.  PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.

Authors:  Bo Zhou; Jingya Wang; Shirley Y Lee; Jie Xiong; Natarajan Bhanu; Qi Guo; Peilin Ma; Yuqing Sun; Rajesh C Rao; Benjamin A Garcia; Jay L Hess; Yali Dou
Journal:  Mol Cell       Date:  2016-04-14       Impact factor: 17.970

3.  Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.

Authors:  Danielle C Shing; Maurizio Trubia; Francesco Marchesi; Enrico Radaelli; Elena Belloni; Cinzia Tapinassi; Eugenio Scanziani; Cristina Mecucci; Barbara Crescenzi; Idoya Lahortiga; Maria D Odero; Giuseppe Zardo; Alicja Gruszka; Saverio Minucci; Pier Paolo Di Fiore; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

4.  Prdm proto-oncogene transcription factor family expression and interaction with the Notch-Hes pathway in mouse neurogenesis.

Authors:  Emi Kinameri; Takashi Inoue; Jun Aruga; Itaru Imayoshi; Ryoichiro Kageyama; Tomomi Shimogori; Adrian W Moore
Journal:  PLoS One       Date:  2008-12-03       Impact factor: 3.240

5.  RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report.

Authors:  Ioannis Panagopoulos; Synne Torkildsen; Ludmila Gorunova; Aina Ulvmoen; Anne Tierens; Bernward Zeller; Sverre Heim
Journal:  Oncol Rep       Date:  2016-09-22       Impact factor: 3.906

Review 6.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.